Stock Price
8.88
Daily Change
-0.13 -1.44%
Monthly
19.52%
Yearly
185.53%
Q3 Forecast
8.80

Sino Biopharmaceutical reported CNY17.57B in Sales Revenues for its fiscal semester ending in June of 2025.


Sales Change Date
Alaunos Therapeutics USD 0 4K Sep/2024
Avita Medical AUD 18.41M 7.89M Dec/2024
Cspc Pharmaceutical CNY 7.01B 691.61M Mar/2025
Dianthus Therapeutics USD 193K 1.13M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Jiangsu Hengrui CNY 8.6B 1.39B Jun/2025
Moderna USD 142M 34M Jun/2025
Organon & Co USD 1.59B 80M Jun/2025
Revvity USD 720M 55M Jun/2025
Sino Biopharmaceutical CNY 17.57B 1.7B Jun/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.57B 320M Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025